Stocks
Immunomedics (IMMU) EBITDA margin US GAAP (year values) |
|||||||||
| 2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -800.9% | -1 790% | -4 748% | -11 555% | -108 819% | -646.6% | ||
| Changes by years, y/y, % | -415pp | -989pp | -2 958pp | -6 807pp | -97 264pp | +209.1% | |||
Immunomedics. EBITDA margin, %
Immunomedics. EBITDA margin, changes, pp
Immunomedics (IMMU) EBITDA margin US GAAP (quarter values) |
||||||||
| 2019Q4 | 2020Q3 | 2020Q1 | 2020Q4 | 2020Q2 | LTM ? | |||
| EBITDA margin, % | ? | -30 663% | -255.3% | -255.3% | -646.6% | |||
| Changes by years, y/y, % | +30 408pp | |||||||
| Changes by quarters, q/q, % | +30 663pp | 0pp | ||||||
